Jo E Rodgers

Author PubWeight™ 14.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med 2008 3.68
2 Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. Crit Care Med 2008 1.41
3 Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail 2010 1.30
4 Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs. Med Care 2015 0.89
5 Type 2 diabetes mellitus and heart failure. Pharmacotherapy 2008 0.85
6 Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J 2009 0.83
7 Discharge counseling for patients with heart failure or myocardial infarction: a best practices model developed by members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network based on the Hospital to Home (H2H) Initiative. Pharmacotherapy 2013 0.82
8 Clinical update on the management of atrial fibrillation. Pharmacotherapy 2013 0.81
9 Acute decompensated heart failure: evolving literature and implications for future practice. Pharmacotherapy 2013 0.80
10 Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers. Clin Pharmacol Ther 2002 0.78
11 Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee. J Thromb Thrombolysis 2005 0.78
12 Distinguishing anemia and iron deficiency of heart failure: signal for severity of disease or unmet therapeutic need? Pharmacotherapy 2014 0.76
13 Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency. Pharmacotherapy 2014 0.76
14 Expanding role of beta-blockade in the management of chronic heart failure. Pharmacotherapy 2003 0.75
15 A Comparison of Self-reported Medication Adherence to Concordance Between Part D Claims and Medication Possession. Med Care 2017 0.75
16 Reversible cardiomyopathy following treatment with amphotericin B and flucytosine. Int J Antimicrob Agents 2008 0.75
17 High-impact articles related to the management of heart failure: 2008 update. Pharmacotherapy 2009 0.75
18 Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction. Ann Pharmacother 2007 0.75
19 Abciximab-associated thrombocytopenia after previous tirofiban-related thrombocytopenia. Pharmacotherapy 2006 0.75
20 Warfarin and Aspirin Versus Warfarin Alone for Prevention of Embolic Events in Patients with a HeartMate II® Left Ventricular Assist Device. ASAIO J 2017 0.75
21 High-impact articles related to the pharmacotherapeutic management of systolic heart failure. Pharmacotherapy 2004 0.75
22 Substitution of a heparin correlation value for activated partial thromboplastin time in heparin nomograms. Am J Health Syst Pharm 2011 0.75
23 Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update. Pharmacotherapy 2012 0.75